| Original language | English (US) |
|---|---|
| Pages (from-to) | 846-848 |
| Number of pages | 3 |
| Journal | Neurology |
| Volume | 78 |
| Issue number | 12 |
| DOIs | |
| State | Published - Mar 20 2012 |
ASJC Scopus subject areas
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Neurology, Vol. 78, No. 12, 20.03.2012, p. 846-848.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Pregnancy A "modifiable" risk factor in MS?
AU - Daumer, Martin
AU - Weinshenker, Brian G.
AU - Voskuhl, Rhonda
N1 - Funding Information: Dr. Daumer serves on the scientific advisory board for EPOSA study; has received funding for travel from ECTRIMS; serves on the editorial board of MedNous; is author on patents re: Apparatus for measuring activity (Trium Analysis Online GmbH), Method and device for detecting a movement pattern (Trium Analysis Online GmbH), Device and method to measure the activity of a person, Device and method to determine the fetal heart rate from ultrasound signals, Method and device for detecting drifts, jumps and/or outliers of measurement values, Device and method to determine the global alarm state of a patient monitoring system, Method of communication of units in a patient monitoring system, Method and device for detecting drifts, jumps and/or outliers of measurement values, and System and method for patient monitoring; serves as Managing Director of and holds stock/stock options in Trium Analysis Online GmbH (50% effort); serves as a consultant for University of Oxford, Imperial College London, University of Southampton, Charite, Berlin, University of Vienna, Greencoat Ltd, Biopartners, Biogen Idec, Bayer Schering Pharma, Roche, and Novartis; and receives/has received research support from the EU-FP7, BMBF, BWiMi, and Hertie Foundation. Dr. Weinshenker serves on data safety monitoring boards for Novartis and Biogen Idec; serves on the editorial boards of the Canadian Journal of Neurological Sciences, the Turkish Journal of Neurology, and Multiple Sclerosis; has received research support from the Guthy-Jackson Charitable Foundation; and receives license royalties from RSR Ltd. for a patent re: Aquaporin-4 associated antibodies for diagnosis of neuromyelitis optica. Dr. Voskuhl is an inventor on a UCLA patent for estriol treatment in MS, for which she has received royalties; serves as a consultant for Adeona Pharmaceuticals; and has received research support from the National Multiple Sclerosis Society, the NIH (NINDS, NIAMS), the Skirball Foundation, the Conrad Hilton Foundation, and the Sherak Family Foundation.
PY - 2012/3/20
Y1 - 2012/3/20
UR - http://www.scopus.com/inward/record.url?scp=84860321328&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860321328&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e31824d1858
DO - 10.1212/WNL.0b013e31824d1858
M3 - Editorial
C2 - 22402865
AN - SCOPUS:84860321328
SN - 0028-3878
VL - 78
SP - 846
EP - 848
JO - Neurology
JF - Neurology
IS - 12
ER -